Ault Alliance and Imperalis Holdings Announce Effectiveness of Imperalis Holding Registration Statement on Form S-1 Related to the Distribution of Securities
Ault Alliance Announces Change in Exchange Ratio in Pending Exchange Offer to 50 Shares of Common Stock for One Share of Series H Preferred Stock (an increase in consideration to $0.20 per share of Common Stock)
Ault Alliance Announces Alzamend Neuro Has Initiated Its Phase I/IIA Trial for Its Immunotherapy Vaccine (ALZN002) to Treat Mild to Moderate Dementia of the Alzheimer’s Type
Ault Alliance’s Subsidiary, Ault Energy, LLC, Strikes Oil on First Two Joint Drilling Projects, Suggesting a Bright Future With More Wells in the Pipeline
Ault Alliance’s Subsidiary, Ault Energy, LLC, Strikes Oil on First Two Joint Drilling Projects, Suggesting a Bright Future With More Wells in the Pipeline
Ault Alliance Announces Share Buyback of up to 333,333,333 Shares of Common Stock at $0.15 per Share Through Exchange Offer for New Class of Preferred Stock